Repare Therapeutics Inc. revenue breakdown overview

Repare Therapeutics Inc. revenue for the last year amounted to 51.13 M USD, the most of which — 51.13 M USD — came from its highest performing source at the moment, Precision Oncology Drugs, the year earlier bringing 131.83 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Repare Therapeutics Inc. 26.10 M USD, and the year before that — 15.20 M USD.